GlassScriptPhysician profile
Macaira M Dyment
NPI 1740475813
$28,326.48
in general payments reported to CMS, 2019-2025
41 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $298 · 2021: $15K · 2022: $8,541 · 2023: $2,233 · 2024: $1,181 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,753 · Travel and Lodging: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,752.57 |
| Travel and Lodging | $851.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gramercy Extremity Orthopedics LLC | $14,750.00 | 2021-2022 | |
| Kerecis Limited | $7,045.55 | 2020-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $1,525.84 | 2019-2025 | Grafix Pl, Renasys Go V2 Home, Stravix Pl |
| Cdc Medical LLC | $1,214.24 | 2022 | |
| Treace Medical Concepts, INC. | $851.92 | 2023 | |
| Inari Medical, INC. | $471.34 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Access Pro Medical, LLC | $326.49 | 2025 | Matriderm |
| Horizon Therapeutics Plc | $301.23 | 2019-2022 | |
| Organogenesis INC. | $221.50 | 2020-2025 | Puraply, Affinity |
| Medtronic, INC. | $195.42 | 2025 | Inceptiv |
| Solventum Corporation | $156.86 | 2025 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Avita Medical Americas, LLC | $150.44 | 2024 | |
| Flower Orthopedics Coporation | $138.10 | 2019 | |
| Nevro Corp. | $128.16 | 2022-2024 | Senza |
| Bioventus LLC | $95.07 | 2023 | Stimrouter Implantable Kit |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rikco International, LLC | $88.00 | 2019 | |
| Urgo Medical North America, LLC | $87.17 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Paratek Pharmaceuticals, INC. | $67.69 | 2023-2024 | Nuzyra |
| Ani Pharmaceuticals, INC. | $49.35 | 2024 | Purified Cortrophin Gel |
| Paragon 28, INC. | $40.60 | 2019-2020 | |
| Misonix INC | $39.65 | 2020 | |
| Melinta Therapeutics, LLC | $38.39 | 2019 | |
| Orthofix Medical, INC. | $29.66 | 2019-2024 | Accelstim |
| Integra Lifesciences Corporation | $28.14 | 2020 | |
| Cashflow Solutions, LLC | $26.36 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Stryker Corporation | $25.37 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.57 | 2024 | Exparel, Iovera, Zilretta |
| Tactile Systems Technology INC | $21.11 | 2025 | Nimbl, Flexitouch Plus |
| Nabriva Therapeutics, Plc | $18.87 | 2022 | |
| Averitas Pharma INC. | $17.12 | 2024 | Qutenza |
| Ets Wound Care LLC | $17.09 | 2025 | Mirragen Advanced Wound Matrix |
| Baudax Bio INC. | $16.36 | 2021 | |
| Biocomposites INC | $15.80 | 2024-2025 | Stimulan |
| Zimmer Biomet Holdings, INC. | $14.98 | 2021 | |
| Checkpoint Surgical, INC | $13.55 | 2020 | |
| Depuy Synthes Sales INC. | $13.24 | 2021 | |
| Merck Sharp & Dohme LLC | $13.19 | 2019 | |
| Bsn Medical INC | $12.35 | 2022 | |
| Arteriocyte Medical Systems, INC. | $12.32 | 2021 | |
| Acell, INC. | $12.20 | 2020 | |
| Aroa Biosurgery Incorporated | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macaira Dyment listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.